Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

03. Juni 2024 08:00 ET | Quelle: Rumi Scientific, Inc.

RUMI Scientific announces Receipt of Two-Year Phase II SBIR Award totaling $1.9 Million to Accelerate Discovery and Development of Novel Therapeutic Candidates for the Treatment of Autism

NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- RUMI Scientific, Inc. (“RUMI”) a developer of therapies for rare and neurodegenerative diseases using its high throughput organoid phenotypic screening...
05. Dezember 2023 08:00 ET | Quelle: Rumi Scientific, Inc.

Rumi Scientific Announces Partnership with X-Chem for Development of Lead Candidate in Huntington’s Disease

NEW YORK, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Rumi Scientific (“Rumi”), a developer of therapies for rare and neurodegenerative diseases using its high throughput organoid phenotypic screening...
26. April 2023 07:05 ET | Quelle: Rumi Scientific, Inc.

Rumi Scientific Announces Data Demonstrating Disease Modifying Effect of BRD9 Inhibition in a Huntington’s Disease Animal Model

NEW YORK, April 26, 2023 (GLOBE NEWSWIRE) -- Rumi Scientific (“Rumi”), a developer of therapies for rare and neurodegenerative diseases discovered using its high throughput organoid phenotypic...
30. März 2023 08:00 ET | Quelle: Rumi Scientific, Inc.

Rumi Scientific Appoints Allen A. Fienberg, Ph.D., as Chief Executive Officer and Chairman of the Board of Directors

NEW YORK, March 30, 2023 (GLOBE NEWSWIRE) -- Rumi Scientific (“Rumi”), a developer of therapies for rare and neurodegenerative diseases discovered using its high throughput organoid phenotypic...